Literature DB >> 6844949

Participation in faecal occult blood screening for colorectal cancer.

O F Dent, R Bartrop, K J Goulston, P H Chapuis.   

Abstract

Chemical faecal occult blood testing has been proposed as a means of screening for colorectal cancer (C.C.) in populations or in identified high-risk groups. The level of public participation is a critical factor in the effectiveness of screening programmes. This study was conducted as a methodological pretest for an intended investigation of factors influencing screening participation. Faecal occult blood screening was offered to 728 employees of a teaching hospital in Sydney, New South Wales and 41% participation was obtained. Both participants and non-participants were questioned on demographic and social background factors, on their experience of C.C. in others, and on their reasons for participating or not participating. Major reasons for participation were: a general feeling of the importance of health checks and screening tests; a belief that it is important to diagnose C.C. early; and the fact that the test was simple and easy to do. Prominent self-acknowledged reasons for non-participation were indifference, procrastination, absence of previous bowel complaints, preference for one's own doctor to do such tests and inconvenience or lack of time. Those more likely to participate were: females; those of Australian or British origin; single, separated or divorced persons; those having two or more dependents and those with personal knowledge of a C.C. patient.

Entities:  

Mesh:

Year:  1983        PMID: 6844949     DOI: 10.1016/0277-9536(83)90074-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  9 in total

1.  Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.

Authors:  Y Niv; M Lev-El; G Fraser; G Abuksis; A Tamir
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Facilitating factors for colorectal cancer screening.

Authors:  Corey H Brouse; Randi L Wolf; Charles E Basch
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

3.  Colorectal screening patterns and perceptions of risk among African-American users of a community health center.

Authors:  I M Lipkus; B K Rimer; P R Lyna; A A Pradhan; M Conaway; C T Woods-Powell
Journal:  J Community Health       Date:  1996-12

Review 4.  Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 5.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Psychosocial variables associated with colorectal cancer screening in South Australia.

Authors:  Stephen R Cole; Ian Zajac; Tess Gregory; Sarah Mehaffey; Naomi Roosa; Deborah Turnbull; Adrian Esterman; Graeme P Young
Journal:  Int J Behav Med       Date:  2011-12

7.  Compliance with fecal occult blood testing: the role of restrictive diets.

Authors:  A Joseph
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

8.  Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.

Authors:  Nancy P Gordon; Beverly B Green
Journal:  BMC Public Health       Date:  2015-06-11       Impact factor: 3.295

9.  Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.

Authors:  C K Palmer; M C Thomas; C von Wagner; R Raine
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.